VANESSA ALMANZA: Open Payments
NPI 1720847478 · VALPARAISO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,186 in 141 payments from 33 companies in 2025. Trend: 2023 $0 · 2024 $372 · 2025 $3,186
Food & beverage: $3,121Education: $65
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $510 |
| JAZZ PHARMACEUTICALS INC. | 9 | $279 |
| Biogen, Inc. | 8 | $205 |
| Lilly USA, LLC | 5 | $190 |
| CATALYST PHARMACEUTICALS, INC. | 8 | $184 |
| Janssen Biotech, Inc. | 12 | $172 |
| ARGENX US, INC. | 9 | $163 |
| TG Therapeutics, Inc. | 4 | $111 |
| UCB, Inc. | 3 | $108 |
| Mallinckrodt Hospital Products Inc. | 4 | $106 |
Products named: EPIDIOLEX, TYSABRI, FYCOMPA, QULIPTA, UBRELVY, BOTOX, BRIUMVI, ACTHAR.
Industry payments across IN — which companies pay providers there.
